scholarly article | Q13442814 |
P50 | author | Bob Löwenberg | Q71513060 |
P2093 | author name string | Peter J M Valk | |
Ellen van Drunen | |||
H Berna Beverloo | |||
Justine K Peeters | |||
Saman Abbas | |||
Jasper E Koenders | |||
Mathijs A Sanders | |||
Remco Hoogenboezem | |||
Annelieke Zeilemaker | |||
Isabel W T Chu | |||
Wendy M C Geertsma-Kleinekoort | |||
Francois G Kavelaars | |||
Janneke van Galen | |||
Souad Mahamoud | |||
Zabiollah G Abbas | |||
P2860 | cites work | BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes | Q24294962 |
Recurring mutations found by sequencing an acute myeloid leukemia genome | Q24634204 | ||
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome | Q24644436 | ||
DNMT3A Mutations in Acute Myeloid Leukemia | Q27559610 | ||
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia | Q27851759 | ||
14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia | Q68840106 | ||
Cytogenetics of childhood acute nonlymphocytic leukemia | Q69675957 | ||
Is t(6;14) a non-random translocation in childhood acute mixed lineage leukemia? | Q71466818 | ||
Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias | Q81369406 | ||
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers | Q84150307 | ||
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern | Q84668776 | ||
Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas | Q28508746 | ||
Bcl11a is essential for normal lymphoid development | Q28511014 | ||
Bcl11b is required for differentiation and survival of αβ T lymphocytes | Q28592191 | ||
Super-enhancers in the control of cell identity and disease | Q28661442 | ||
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia | Q29614324 | ||
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders | Q29614510 | ||
Selective inhibition of tumor oncogenes by disruption of super-enhancers | Q29617301 | ||
Mutation in TET2 in myeloid cancers | Q29619292 | ||
A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. | Q33182502 | ||
SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels | Q33316565 | ||
Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation | Q33686984 | ||
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH). | Q34230063 | ||
The TLX1 oncogene drives aneuploidy in T cell transformation | Q34283329 | ||
A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. | Q34315758 | ||
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. | Q34387780 | ||
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter | Q34441819 | ||
Acquired mutations in TET2 are common in myelodysplastic syndromes | Q34984094 | ||
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation | Q34996567 | ||
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia | Q35483684 | ||
Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value | Q35794435 | ||
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. | Q36141686 | ||
p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. | Q36225533 | ||
Genomic assessment of pediatric acute leukemia | Q36273597 | ||
Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation | Q36756480 | ||
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling | Q37059396 | ||
BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes | Q37091336 | ||
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia | Q37172988 | ||
Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity | Q37802423 | ||
Therapeutic advances in acute myeloid leukemia | Q37827282 | ||
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications | Q37827283 | ||
Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects | Q37871413 | ||
Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights | Q37979955 | ||
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. | Q47956567 | ||
Prognostically useful gene-expression profiles in acute myeloid leukemia. | Q51999490 | ||
Acute mixed lineage leukemia and a t(6;14)(q25;q32) in two adults. | Q53463855 | ||
BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia. | Q55038892 | ||
Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype | Q61105436 | ||
Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia | Q62927037 | ||
P433 | issue | 5 | |
P921 | main subject | leukemia | Q29496 |
acute myeloid leukemia | Q264118 | ||
P304 | page(s) | 848-857 | |
P577 | publication date | 2014-01-17 | |
P1433 | published in | Haematologica | Q5638209 |
P1476 | title | Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations | |
P478 | volume | 99 |
Q41367937 | A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. |
Q38692964 | Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease. |
Q33361902 | Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis? |
Q90663469 | Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia |
Q42777609 | Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia. |
Q34669453 | Kinetic analysis of BCL11B multisite phosphorylation-dephosphorylation and coupled sumoylation in primary thymocytes by multiple reaction monitoring mass spectroscopy |
Q34469099 | Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients |
Q28646898 | Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32) |
Q91812671 | Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia |
Q88095601 | Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells |
Q38686515 | Review: Aberrant EVI1 expression in acute myeloid leukaemia |
Q26998657 | SWI/SNF chromatin remodeling complexes and cancer |
Q89882479 | T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid |
Q92715615 | The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia |
Q91723487 | The global clonal complexity of the murine blood system declines throughout life and after serial transplantation |
Search more.